Internal Medicine for Practice, 2006, issue 3

Editorial

Schopnost a neschopnost

prof. RNDr. Stanislav Komenda DrSc

Interní Med. 2006; 8(3)

Review articles

Hepatorenal syndrome

doc. MUDr. Radan Brůha CSc, MUDr. Jaromír Petrtýl CSc, doc. MUDr. Petr Urbánek CSc, MUDr. Tomáš Švestka, prof. MUDr. Zdeněk Mareček DrSc

Interní Med. 2006; 8(3): 106-108  

Hepatorenal syndrome is a functional renal failure in patients with advanced cirrhosis and portal hypertension or acute liver failure. It is caused by extreme vasoconstriction in renal arterial bed. Type I HRS presents as an acute renal failure, while type II HRS is chronic alteration of renal function in patients with refractory ascites. Prognosis of HRS is very poor with survival reaching several weeks in patients with HRS type I. Causal treatment is liver transplantation, other treatment options include use of splanchnic vasoconstrictors (terlipressin) together with plasmaexpansion (albumin) and TIPS. It is important to exclude nephrotoxic medication...

Probiotics in prophylaxis and therapy of tumours and vulvovaginitis

PharmDr. Miloslav Hronek Ph.D, Mgr. Zdeňka Kudláčková, PharmDr. Petr Jílek CSc, MUDr. Dana Hrnčiariková

Interní Med. 2006; 8(3): 109-111  

Probiotics in oncology play the most important role in prophylaxis of pathogenesis of colorectal tumour. Antitumour properties of probiotics take part in the inhibition of genotoxicity of carcinogens and suppression of carcinogen-induced preneoplastic lesions and tumours. In prophylaxis of vaginal candidosis oral application of Lactobacillus rhamnosus GR-1 and L. fermentum FC-14, B-54 is recommended. Further, L. Brevis CD-2, L. salivarius FV-2, L. gasseri MB 335, L. plantarum appear to be suitable in forms of gel capsules (L. plantarum) or vaginal tablets (L. gasseri). Strains of L. acidophilus CRL 1294 and L. salivarius CRL 1328 show the ability of...

Chronic fatigue and chronic fatigue syndrome

doc. MUDr. Jaromír Bystroň CSc

Interní Med. 2006; 8(3): 112-115  

About 20% of population complains of symptoms of persistent fatigue. Most of the cases could be explained by contemporary medical knowledge and treated adequately “lege artis”. In spite of this fact there are patients in whom we neither can by all diagnostic and therapeutic effort establish the diagnosis nor the appropriate treatment. Such patients are classified under the diagnosis of chronic fatigue syndrome. It is necessary to realize that these patients form a considerably heterogeneous group with chronic fatigue as the only unifying factor, and this diagnosis is only provisional. It is an obligation of all physicians who are dealing...

Masked Hypertension and ambulatory blood pressure monitoring

doc. MUDr. Andrej Dukát CSc

Interní Med. 2006; 8(3): 116-118  

Masked hypertension represents nowadays the new entity in clinical practice of hypertension. Represents higher ambulatory blood pressure, than conventionally measured office blood pressure. In the near future follow-up of its reproducibility and its clinical significance are going to be estimated.

Some new therapeutics for postmenopausal osteoporosis

prof. MUDr. Vladimír Palička CSc, doc. MUDr. Pavel Živný CSc, MUDr. Ladislava Pavlíková

Interní Med. 2006; 8(3): 119-122  

The Recommended Guidelines for diagnostics and therapy of primary postmenopausal osteoporosis are still valid and basic steps – supplementation of calcium and vitamin D are basic stones of successful therapy. Hormonal replacement therapy is not considered as a primary and first choice therapy; it is considered as a therapy of menopausal syndrome with positive effect on bone metabolism. Antiresorptive drugs on the Czech market (bisphosphonates, calcitonine, selective estrogen receptor modulators) were enhanced by two osteoanabolic drugs. Stroncium ranelate is the first drug with dual effect on bone metabolism: osteoanabolic and antiresorptive....

Severe asthma

MUDr. Milan Teřl Ph.D

Interní Med. 2006; 8(3): 123-127  

The majority of patients with asthma can be relatively easily treated thanks to availability of highly effective medications. In only 5% of asth­matics patients is their disease so severe, that available treatment fails (=severe, therapy-resistant asthma). In the reality, however, more than 50% of astmatic patients remains with poorly controlled disease, 1/3 have severe troubles. In the clinic, it is important to distinguish between real severe and so-called difficult asthma. Asthma may be difficult not only because of the disease factor, but more frequently for doctor or patients factors.

THE MOST COMMON INFECTIONS IN INTERNAL MEDICINE

MUDr. Jindra Lochmannová

Interní Med. 2006; 8(3): 128-133  

The published work is an overview of the most common infectious complications in internal medicine. In particular, these are lower respiratory tract infections, urinary infections, cardiovascular infections and gastrointestinal infections, including the most serious one, i.e. septic conditions. Individual infections are listed in tables and divided according to the sites of their origin. Also included are recommended therapies – both initial (mostly for outpatient management) and the so called alternative which can be used either following clinical failure of initial treatment or in severe cases requiring hospitalization. Although these therapeutic...

Information

Snížení hmotnosti u žen s nadváhou a obezitou vysokoproteinovou dietou na bázi sóji

Mgr. Pavel Suchánek, doc. MUDr. Věra Adámková CSc, Mgr. Petr Stávek Ph.D

Interní Med. 2006; 8(3): 148-151  

Náhle srdcové úmrtie a šport - II. časť

prof. MUDr. Dušan Meško Ph.D

Interní Med. 2006; 8(3): 152-154  

Case report

Kryptokokóza u nemocného s progredující chronickou b-lymfatickou leukémií

Ladislav Slováček, prof. MUDr. Ladislav Jebavý CSc, MUDr. Oldřich Široký, MUDr. Jaroslav Cerman Ph.D, Pavel Žák, MUDr. Petra Benešová, RNDr. Pavel Buchta, MUDr. Martin Blažek, MUDr. Brigita Slováčková Ph.D, MUDr. Jan M. Horáček Ph.D

Interní Med. 2006; 8(3): 135-137  

Optimalizace léčby chronického srdečního selhání ace inhibitory a betablokátory

doc. MUDr. Ivan Málek CSc

Interní Med. 2006; 8(3): 138-141  

Účinnost a bezpečnost ambulantní léčby hluboké žilní trombózy nadroparinem

prof. MUDr. Jaroslav Malý CSc, doc. MUDr. Petr Dulíček Ph.D, doc. MUDr. Miroslav Pecka Ph.D, MUDr. Radovan Malý Ph.D, doc. MUDr. Libuše Vodičková CSc

Interní Med. 2006; 8(3): 142-147  

At a glance

Současný stav péče o akutní ischemické cévní mozkové příhody v ČR

MUDr. Daniel Václavík

Interní Med. 2006; 8(3): 134  


Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.